Exchange: NASDAQ·Updated 07:12 PM EDT
ACLX logo

ACLX Arcellx Inc

$115.12
$0.04
(0.04%)
Today
Closed $115.07
$0.05
(0.04%)
After Hours
Reported EarningsNov 5
Mkt Cap$6.73B
Vol14.67M

About ACLX

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Redwood City MD.
45

Neutral Sentiment

How do you feel about ACLX?

Advertisement|Remove ads.